Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
-
GLOBAL’s AcceptAbility Gala Raises $430,000 for Down Syndrome Research and Medical Care as Celebrities and Congressional Leaders Rally Behind the Cause
-
AIFA Provides Update on Nasdaq Notice and Filing of Annual Report, Clearing Key Pathways for Strategic Transformation
-
Crypto News: AlphaPepe Presale Q2 PancakeSwap Listing Nears as Bitcoin Price Prediction Targets $200,000
-
Fushi Tech Unveils AI Agent Strategy Targeting Overseas Merchants
-
Liminatus Pharma Announces Nasdaq Delisting Notification
-
Peyto Exploration & Development Corp. Announces Voting Results From Annual General Meeting of Shareholders
-
Purecore Engages HEG & Associates for its 2026 Exploration Program at the Bankier Property
-
Rocket Lab Awarded $90M Contract to Build GEO Satellites Hosting Space Domain Awareness Payload for U.S. Space Force
-
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
-
Rocket Lab Awarded $90M Contract to Build GEO Satellites Hosting Space Domain Awareness Payload for U.S. Space Force
-
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting
-
TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study
-
Mason Street Wealth Management Introduces Vision-First Retirement Planning Approach to Help Clients Build Financial Confidence
-
FortuneX Acquisition Corporation Prices Initial Public Offering
-
Anker Innovations Announces Multi-Year Partnership with Tomorrowland
-
Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M
-
Carolina Financial Services Group Tackles Retirement’s “Double Threat”: How Tax and Healthcare Risks Impact Retirees
-
Swiss Water Reports Voting Results from Annual General and Special Meeting of Shareholders
-
Licensing Expo Concludes with Record-Breaking Show Floor and Participation from Cultural Icons, Cementing Status as Global Epicenter for Brand Collaboration
-
VVC Exploration Corporation Provides Regulatory Update and Clarifies a Previous Incorrect Statement about CYRB
-
Anker Unveils Next-Generation Products Across Brands at Anker Day 2026
-
American Hotel Income Properties REIT LP Announces Annual and Special Meeting of Unitholders
-
EMGA arranges USD 15m financing for Asia Alliance Bank from OeEB
-
Descendant of Boxing Legends Unearths Lost American Epic in THE ST. PAUL PHANTOM: The Gibbons Brothers’ Fight for Glory, Volume I
-
CORRECTION – Canadian Banc Corp. Monthly Dividend Declaration for Class A & Preferred Share
-
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
-
Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era
-
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
-
Prairie Provident Reports on AGM Voting Results
-
Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
-
Mountain America Credit Union Ranked Among USA Today’s Top 10 Workplaces for Third Consecutive Year
-
Modaxo Enters into Agreement to Acquire the Public Transit Business from Conduent
-
nVent to Participate in Upcoming Investor Conference
-
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at
-
Peace Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
-
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
-
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
-
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
-
Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
-
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
-
Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
-
Equus Announces First Quarter Net Asset Value
-
Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season
-
Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical O
-
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
-
North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders
-
Imperial Announces Voting Results for the Election of Directors
-
Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin
-
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
